Cancer

Promising Gene Therapy Trials Suspended Over Potential Cancer Risk

Promising Gene Therapy Trials Suspended Over Potential Cancer Risk

On Tuesday, Biotech company Bluebird suspended its trials of gene therapy as a treatment for blood-related disorders over concerns of a possible increased risk of cancer. The company cited the recent discovery of two patients given the experimental treatment who developed a form of blood cancer, along with a similar case…